Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

Needham analyst Ryan MacDonald has reiterated their bullish stance on COUR stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

However, high correlation to crude can be a double-edged sword, as many energy investors experienced when crude prices ...

Citi analyst Ariel Rosa adjusted the price target for UPS (NYSE:UPS) stock, bringing it down to $149 from the previous target ...

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

The near term technicals are highly bullish as the chart, moving averages, and indicators show that the outlook is strong.

We recently compiled a list of the 10 Important AI News and Ratings for Today. In this article, we are going to take a look ...

The endorsement from Benchmark comes amidst a favorable outlook for the cinema advertising sector, which is poised to benefit ...

Esports revenue includes media rights, ticket sales, sponsorship and advertising deals, but the entire gaming industry ...

Here are three smaller-cap companies with lower-priced stocks that could offer patient investors enormous returns for the ...

Out of the 41 analysts that have coverage on Sun Pharma, 30 of them have a 'Buy' rating on the stock. Seven of them have a ...

Rocket Lab stock shows 540% returns with risks like valuation and dilution with long-term potential similar to SpaceX's ...